InMed Pharmaceuticals (INM) Enterprise Value: 2021-2025
Historic Enterprise Value for InMed Pharmaceuticals (INM) over the last 4 years, with Sep 2025 value amounting to -$4.2 million.
- InMed Pharmaceuticals' Enterprise Value fell 71.28% to -$4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.6 million, marking a year-over-year increase of 10.19%. This contributed to the annual value of -$7.2 million for FY2025, which is 63.71% down from last year.
- As of Q3 2025, InMed Pharmaceuticals' Enterprise Value stood at -$4.2 million, which was up 41.33% from -$7.2 million recorded in Q2 2025.
- InMed Pharmaceuticals' 5-year Enterprise Value high stood at $7.4 million for Q1 2022, and its period low was -$9.6 million during Q4 2022.
- Over the past 3 years, InMed Pharmaceuticals' median Enterprise Value value was -$4.5 million (recorded in 2023), while the average stood at -$4.5 million.
- In the last 5 years, InMed Pharmaceuticals' Enterprise Value plummeted by 982.29% in 2023 and then surged by 98.14% in 2024.
- InMed Pharmaceuticals' Enterprise Value (Quarterly) stood at $7.2 million in 2021, then slumped by 233.49% to -$9.6 million in 2022, then climbed by 23.01% to -$7.4 million in 2023, then skyrocketed by 98.14% to -$137,315 in 2024, then crashed by 71.28% to -$4.2 million in 2025.
- Its Enterprise Value was -$4.2 million in Q3 2025, compared to -$7.2 million in Q2 2025 and -$2.2 million in Q1 2025.